In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-24 of 24 for your search:
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ACTG A5264, 1U01AI068636, NCT01352117

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ACTG A5263, 1U01AI068636, U01CA121947, NCT01435018

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120047, 12-C-0047, NCT01495598

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: STH16059, 2011-003099-35, NCT01752569

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 140176, 14-C-0176, NCT02228512

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 090130, 09-C-0130, NCT00923936

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: STH15195, 2008-006007-23, NCT01140737

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: C41-10, NCT01296815

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALDOXORUBICIN-P2-KS-01, NCT02029430

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-089, NCI-2014-00638, U01CA121947, NCT02137564

11.

Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NAV3-12, NCT02201420

12.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: Over 18 to 80
Sponsor: Other
Protocol IDs: P130944, 2014-001741-24, NCT02212639

13.

Phase: Phase I
Type: Diagnostic, Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 9361700212, NTUH-94M29, NCT00154921

14.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0493, 1R21DE016485-01, NCT00432471

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-058, U01CA121947, CDR0000590397, NCT00695422

16.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: J09111, NA_00032681, P01CA015396, NCT00982449

17.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 010038, 01-C-0038, NCT00006518

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Not specified
Sponsor: NIAID
Protocol IDs: 999907018, 07-CC-N018, NCT00395278

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110220, 11-C-0220, NCT01419561

20.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: not specified
Sponsor: NCI
Protocol IDs: 999906194, 06-C-N194, NCT00904579

21.

Phase: No phase specified
Type: Health services research, Natural history/Epidemiology
Status: Active
Age: 1 to 80
Sponsor: Other
Protocol IDs: 12-0816, NCT01764360

22.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRO2009, CHERUB 003-301, NCT01902693

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J13174, NA_00092477, NCT02080416

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: 960102, 96-C-0102, NCT00001506
New Search